Dr. Daniel Przybysz (born March 25, 1988) is a Brazilian Radiation-Oncologist. His practice is mainly focused on

lung cancer Lung cancer, also known as lung carcinoma (since about 98–99% of all lung cancers are carcinomas), is a malignant lung tumor characterized by uncontrolled cell growth in tissue (biology), tissues of the lung. Lung carcinomas derive from tran ...

treatment and high technology approaches toward better patient care. Przybysz has a medical degree from the Federal University of Parana, Brazil jointly with

Harvard Medical School Harvard Medical School (HMS) is the graduate medical school of Harvard University and is located in the Longwood Medical Area of Boston, Massachusetts. Founded in 1782, HMS is one of the oldest medical schools in the United States and is consi ...

. He graduated in 2013 with high-honors after doing his internships in Oncology-related rotations. After spending some time at the

Massachusetts General Hospital Massachusetts General Hospital (Mass General or MGH) is the original and largest teaching hospital of Harvard Medical School located in the West End neighborhood of Boston, Massachusetts. It is the third oldest general hospital in the United Stat ...

in Boston and at the University of Texas

MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center (colloquially MD Anderson Cancer Center) is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the U.S. and one of the original three comprehensive cancer centers ...

, Przybysz began a Radiation-Oncology program at the Brazilian National Cancer Institute. He graduated residency and was invited to start a position as Visitor Researcher in Radiation-Oncology at the

Washington University in St. Louis Washington University in St. Louis (WashU or WUSTL) is a private research university with its main campus in St. Louis County, and Clayton, Missouri. Founded in 1853, the university is named after George Washington. Washington University is r ...

. Przybysz also works as an Oncology Reviewer for

UpToDate UpToDate, Inc. is a company in the Wolters Kluwer Health division of Wolters Kluwer whose main product is UpToDate, a software system that is a point of care, point-of-care medical resource. The UpToDate system is an Evidence-based medicine, evide ...

and as an author, editor and reviewer for lung-related articles at the International Journal of Radiation Oncology, Biology and Physics, contributing on high-level reviews for medical content.

Publications

Przybysz's interest in clinical cancer research and outcomes has culminated in several publications, some of listed below: * * * * Magnetic Resonance Image-Guided Radiation Therapy (MR-IGRT) for the Treatment of Prostate Cancer: Initial Patient Selection and Clinical Experience - Journal of Urology 2017 * Lung SBRT using MRI-guided radiation therapy: possible GTV changes and benefits of adaptive therapy In Silico Trial of MR-Guided Mid-Treatment Adaptive Planning for Hypofractionated Stereotactic Radiotherapy in Centrally Located Thoracic Tumors - IJROBP 2016 * Lung SBRT using MRI-guided radiation therapy: possible GTV changes and benefits of adaptive therapy - SBRT 2016 * * A comparison between VMAT, IMRT and GAP techniques on the Medulloblastoma approach: different technologies aiming better patient care - Radiology 2015 * Potential benefits of Neoadjuvant Radiation Therapy On Overall Survival in Advanced Breast Cancer Patients - Radiology 2016 * * Nevertheless, Przybysz is now developing projects using high-technology treatment planning towards better patient care. At present, he is engaged in several studies regarding lung cancer, CNS malignancies and prostate cancer. He has been recognized and awarded as a Leading Physician of The World by the International Association of Healthcare Providers in 2017.

References

{{DEFAULTSORT:Przybysz, Daniel Brazilian oncologists Living people Federal University of Paraná alumni Washington University in St. Louis people 1988 births